PAR 2.50% 20.5¢ paradigm biopharmaceuticals limited..

research reports and media, page-2997

 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.